Study finds AI reduces underdiagnosis of Black patients with common heart failure
Heart failure with preserved ejection fraction makes up 50% of all UK heart failure cases
Read More
Tag: King’s College London
International researchers use shear waves to map blood vessel structures
The findings could improve cancer treatment and drug delivery to treat tumours
Read More
KCL and UCL scientists develop accurate AI brain imaging model for research
In the UK, there are an estimated 11 million people living with a neurological condition
Read More
MRC and MND Association award £3.9m to KCL and UCL for ALS/FTD research
Researchers aim to explore and investigate axonal dysfunction in neurodegeneration
Read More
Janssen’s psoriasis drug shows promise for childhood diabetes
Type 1 diabetes accounts for approximately 10% of diabetes cases in the UK
Read More
New study reveals certain bacteria are toxic for head and neck cancer
Head and neck cancer is currently recognised as the sixth most common cancer globally
Read More
New gut microbiome atlas could offer better treatment for digestive disorders
The new Human Gut Microbiome Atlas could help treat conditions including IBS and AMR
Read More
KCL study finds cell ageing could reveal early signs of neurodegenerative disease
Conditions such as Alzheimer’s and Parkinson’s affect over one million people in the UK
Read More
KCL leads first guidelines on immune monitoring for hard-to-treat blood cancer
Myelodysplastic syndromes are a group of blood cancers that currently affect more than 7,000 people in the UK
Read More
New policy review reveals ten cancer challenges facing new UK government
Macmillan Cancer Support estimates that cancer affects over three million people in the UK
Read More
Study finds headache drug could prevent overuse of acute migraine medications
Chronic migraine is a neurological condition estimated to affect up to 2.2% of people globally
Read More
UCL begins first UK deep brain stimulation study for children with rare epilepsy
Lennox-Gastaut syndrome affects up to 5% of children living with paediatric epilepsy
Read More
- MRM Health collaborates with Oncode Institute and Netherlands Cancer Institute
- Sobi to acquire Arthrosi Therapeutics, strengthening gout treatment pipeline
- Lindus Health and Quotient Sciences announce strategic partnership to accelerate drug development
- Title21 Health Solutions joins the Blood and Cells Advocacy Roster
- NADMED launches $30,000 metabolomics research award
